Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

LEXXLEXX
Showing 2 of 11 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in LEXARIA BIOSCIENCE CORP

Yes. Citadel Advisors holds 156,945 shares of LEXX (Lexaria Bioscience), worth $87,889, as of its Q2 2026 13F filing. It increased the position from 13,513 shares in Q1 2026. Citadel Advisors has held LEXX since Q1 2026, across 2 quarterly 13F filings.

Current Value

$87,889

Current Shares

156,945

Total Value Change

+$77,349

Total Shares Change

+143,432

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
156,945
+1061.4%
$87,8890.0%$8.40
24
2026-Q1
New
13,513
-
$10,5400.0%$11.70
26

Other major holders of LEXX: GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used